Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma
The Internet Journal of Oncology · 2007
DOI: 10.5580/1669 ↗At a glance
Journal article in The Internet Journal of Oncology, 2007.
Abstract (original language)
Objective
The aim of the study is to determine the frequency of antibodies to hepatitis C virus among Nigerian patients with hepatocellular carcinoma.
Method
The study was prospective. Patients with histologically confirmed hepatocellular carcinoma were studied. Sera of the patients were tested for hepatitis C virus antibodies using a third generation ELISA.
Results
A total of 108 patients consisting of 81 males and 27 females were studied, giving a male to female ratio of 4:1. Their ages ranged from 22 to 75 years with a mean of 48 years (SD±13.0). The highest incidence of hepatocellular carcinoma was found among those aged 4049 years. A total of 19 patients (17.6%) were positive for HCV antibodies. There was no significant difference in the frequencies of these antibodies between the male and female patients.
Conclusion
HCV plays a significant role in the etiology of hepatocellular carcinoma in Nigeria. Therefore, patients with chronic hepatitis C should be screened for HCC on regular basis.
Cite
APA
(2007). Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma. The Internet Journal of Oncology. https://doi.org/10.5580/1669
Vancouver
Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma. The Internet Journal of Oncology. 2007. doi:10.5580/1669
BibTeX
@article{euvimed2007,
title = {Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma},
journal = {The Internet Journal of Oncology},
year = {2007},
doi = {10.5580/1669}
}
EUVIMED